MedPath
FDA Approval

Modafinil

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Apotex Corp.
DUNS: 845263701
Effective Date
December 4, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Modafinil(100 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Apotex Inc

209429182

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Modafinil

Product Details

NDC Product Code
60505-2526
Application Number
ANDA077667
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
December 4, 2023
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
ModafinilActive
Code: R3UK8X3U3DClass: ACTIBQuantity: 100 mg in 1 1
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
METHYLCELLULOSE (15 MPA.S)Inactive
Code: NPU9M2E6L8Class: IACT

Modafinil

Product Details

NDC Product Code
60505-2527
Application Number
ANDA077667
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
December 4, 2023
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
METHYLCELLULOSE (15 MPA.S)Inactive
Code: NPU9M2E6L8Class: IACT
ModafinilActive
Code: R3UK8X3U3DClass: ACTIBQuantity: 200 mg in 1 1
© Copyright 2025. All Rights Reserved by MedPath